首页 | 本学科首页   官方微博 | 高级检索  
     

重组人促红细胞生成素对慢性高眼压致大鼠视网膜神经元损伤的保护作用
引用本文:高莉茉,段宣初,胡妙妙. 重组人促红细胞生成素对慢性高眼压致大鼠视网膜神经元损伤的保护作用[J]. 国际眼科杂志, 2009, 9(4): 680-683. DOI: 10.3969/j.issn.1672-5123.2009.04.021
作者姓名:高莉茉  段宣初  胡妙妙
作者单位:1. 中南大学湘雅三医院眼科,中国湖南省长沙市,410013
2. 中南大学湘雅二医院眼科,中国湖南省长沙市,410011
摘    要:目的:探讨玻璃体内注射重组人促红细胞生成素(recombinant human erythropoietin,rHuEPO)对慢性高眼压所致的大鼠视网膜神经元损伤的保护作用及其可能的作用机制。方法:健康SD大鼠30只随机分为5组,每组6只,分别为损伤组I,损伤组Ⅱ、DMSO组、rHuEPO组和rHuEPO+Wortmannin(WM)组。各组均以右眼为实验眼,损伤组Ⅱ大鼠激光处理1d后处死,其余各组激光处理8wk后处死。损伤组用532nm激光烧灼大鼠角巩膜缘浅层静脉,阻断房水回流的方法建立大鼠慢性高眼压模型,采用Tono-pen眼压计测量眼压。DMSO组、rHuEPO组和rHuEPO+WM组大鼠均在激光处理后1d开始分别向玻璃体内注射DM-SO、rHuEPO和rHuEPO+WM,1次/wk。正常对照组选取损伤组左眼作为对照眼。用免疫组织化学法和TUNEL染色检测观察各组实验结果。结果:与正常对照组比较,各组视网膜神经节细胞层(retinal ganglion cell layer,RGCL)中促红细胞生成素受体(erythropoirtin receptor,EPOR)表达增加,差异具有统计学意义(P<0.05)。与正常对照组比较,各组RGCL中蛋白激酶B(AKT)表达无明显改变,差异无统计学意义,损伤组I和DMSO组RGCL中磷酸化蛋白激酶B(PAKT)表达也无明显改变,但rHuEPO组RGCL中PAKT表达增加(P<0.05)。与损伤组I和DMSO组比较,rHuEPO组RGCL中凋亡神经细胞数目减少(P<0.05)。与rHuEPO组比较,rHuEPO+WM组RGCL中AKT表达无明显变化,但PA-KT表达减少(P<0.05),凋亡神经细胞数目增加(P<0.05)。结论:rHuEPO对慢性高眼压所致的大鼠视网膜神经元损伤有保护作用,且rHuEPO通过PI-3K/AKT信号途径抑制神经细胞凋亡而发挥其视神经保护作用。

关 键 词:促红细胞生成素  视网膜神经细胞  细胞凋亡  信号途径  神经保护

Neuroprotection of recombinant human erythropoietin on chronic ocular hyperten-sion induced retinal neuron injury in rats
Li-Mo Gao,Xuan-Chu Duan,Miao-Miao Hu. Neuroprotection of recombinant human erythropoietin on chronic ocular hyperten-sion induced retinal neuron injury in rats[J]. International Eye Science, 2009, 9(4): 680-683. DOI: 10.3969/j.issn.1672-5123.2009.04.021
Authors:Li-Mo Gao  Xuan-Chu Duan  Miao-Miao Hu
Affiliation:Li-Mo Gao1,Xuan-Chu Duan2,Miao-Miao Hu21Deptartment of Ophthalmology,the Third Xiangya Hospital,Central South University,Changsha 410013,Hunan Province,China,2Deptartment of Ophthalmology,the Second Xiangya Hospital,Changsha 410011
Abstract:AIM:To evaluate the neuroprotective effect and its possible mechanism of recombinant human erythropoietin (rHuEPO) in chronic ocular hypertension model of Sprague-Dawley (SD) rats. ·METHODS: Thirty healthy SD rats were randomly divided into five groups, which were damaged group I, damaged group Ⅱ, DMSO group, rHuEPO group and rHuEPO+ Wortmannin (WM) group respectively. Each group has six rats, the right eyes were experimental eyes. The rats in damaged group Ⅱ and in other groups were sacrificed in one day and in eight weeks after laser treatment respectively. Chronic ocular hypertension model was induced by episcleral venous occlusion through 532nm laser for rats in damaged group and the Tono-pen was employed to measure intraocular pressure (IOP). DMSO, rHuEPO and rHuEPO+WM were chosen for intravitreal injection for each group, respectively, and intravitreal injection started from the first day after laser treatment and for once each week. The left eye of the damaged group was served as normal group. The change of EPOR, AKT and PAKT expression for each group was characterized in retinal ganglion cell layer (RGCL) by immuneohistochemistry. The amount of neuron apo-ptosis in RGCL was measured by TUNEL staining.·RESULTS: Compared with the normal group, EPOR expression of each group significantly increased after chronic ocular hypertension (P<0.05). Compared with the normal group, AKT expression of each group didn’t change significantly, PAKT expression of the damaged group I and DMSO group either didn’t change significantly, but PAKT expression of rHuEPO group increased remarkably (P<0.05). Compared with the damaged group I and DMSO group, The amount of neuron apoptosis of rHuEPO group decreased obviously (P<0.05). Compared with rHuEPO group, AKT ex-pression didn’t change significantly, PAKT expression decreased remarkably (P<0.05), and the amount of neu-ron apoptosis increased observably (P<0.05) for rHuEPO+ WM group.·CONCLUSION: rHuEPO has neuroprotective effect on chronic ocular hypertension induced retinal neuron injury in SD rats and it is likely that neuroprotective effect were conveyed by activation of the PI-3K/AKT signal pathway.
Keywords:EPO  retinal neuron  apoptosis  signal path-way  neuroprotection  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号